ArticleBioscience reports2018

The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1.

Haihua Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.